Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alx Oncology Holdings Inc (NQ: ALXO )

8.250 -0.050 (-0.60%)
Streaming Delayed Price Updated: 11:07 AM EST, Dec 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alx Oncology Holdings Inc

< Previous 1 2 3 4 Next >
The Latest Analyst Ratings for ALX Oncology Holdings
Via Benzinga
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
From ALX Oncology
Via GlobeNewswire
ALX Oncology Announces November Investor Conference Participation
From ALX Oncology
Via GlobeNewswire
ALX Oncology Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ALX Oncology
Via GlobeNewswire
The Latest Analyst Ratings for ALX Oncology Holdings
Via Benzinga
Why ALX Oncology Stock Is Skyrocketing Today
Investors are cheering the immuno-oncology company's latest clinical trial results. 
Via The Motley Fool
What's Going On With ALX Oncology Stock?
ALX Oncology Holdings Inc (NASDAQ: ALXO) shares are trading higher by 5.9% to $6.76 Thursday morning. The company announced the pricing of a public offering consisting of roughly 7.37 million common... 
Via Benzinga
ALX Oncology Announces Pricing of Public Offering
From ALX Oncology
Via GlobeNewswire
ALX Oncology Announces Proposed Public Offering
From ALX Oncology
Via GlobeNewswire
Where ALX Oncology Holdings Stands With Analysts
Via Benzinga
4 Analysts Have This to Say About ALX Oncology Holdings
Via Benzinga
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2... 
Via Benzinga
Cal-Maine Foods, A10 Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Crude Oil Moves Higher; POINT Biopharma Global Shares Jump
U.S. stocks extended losses toward the end of trading, with the S&P 500 falling around 1.5% on Tuesday. The Dow traded down 1.43% to 32,954.84 while the NASDAQ fell 1.98% to 13,044.24. The S&P 500 also... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
ALX Oncology Holdings Inc. (NASDAQ: ALXO) is One of Tuesday Morning’s Most Active Stocks
Via Investor Brand Network
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
Benzinga 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
ALX Oncology Holdings Inc (NASDAQ: ALXO) released prespecified interim Phase 2 data from its ASPEN-06 trial of evorpacept plus trastuzumab, Cyramza (ramucirumab) and paclitaxel for HER2-positive... 
Via Benzinga
Why Delta Apparel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Gainers VIQ Solutions Inc. (NASDAQ: VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq. 
Via Benzinga
S&P 500, Nasdaq Futures Waver As Focus Turns To JOLTS Data: Why These Analysts Say Expecting A Strong Q4 This Year Is 'Tricky'
Index futures point to a modestly higher opening on Tuesday, while 10-year Treasury yields have surged to over 4.70%, adding to uncertainty about interest rates. 
Via Benzinga
Topics Stocks
Exposures US Equities
ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
From ALX Oncology
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
ALX Oncology to Host Investor Call and Webcast on October 3, 2023 to Share Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
From ALX Oncology
Via GlobeNewswire
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
Via Investor Brand Network
Exposures Product Safety
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures Product Safety
ALX Oncology Realigns Executive Leadership Team
From ALX Oncology
Via GlobeNewswire
ALX Oncology Announces September Investor Conference Participation
From ALX Oncology
Via GlobeNewswire
ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update
From ALX Oncology
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.